Compile Data Set for Download or QSAR
Report error Found 22 of affinity data for UniProtKB/TrEMBL: Q9ULW8
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447757(CHEMBL57818)
Affinity DataIC50: 130nMAssay Description:Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447761(CHEMBL60908)
Affinity DataIC50: 170nMAssay Description:Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447759(CHEMBL3113470)
Affinity DataIC50: 390nMAssay Description:Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447758(CHEBI:9287 | NSC-45383 | Nigrin | Rufocromomycin |...)
Affinity DataIC50: 430nMAssay Description:Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355665(CHEMBL1910971)
Affinity DataIC50: 690nMAssay Description:Irreversible inhibition of PAD3 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50447760(CHEMBL58150)
Affinity DataIC50: 710nMAssay Description:Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM80075(7-bromo-6-methoxyquinoline-5,8-dione | cid_265935 ...)
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535204(CHEMBL4468883)
Affinity DataIC50: 5.40E+3nMAssay Description:Inhibition of recombinant human 6His-tagged PAD3 expressed in Escherichia coli BL21-DE3 pLysS assessed as reduction in residual activity preincubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535203(CHEMBL4473416)
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of recombinant human 6His-tagged PAD3 expressed in Escherichia coli BL21-DE3 pLysS assessed as reduction in residual activity preincubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535206(CHEMBL4464539)
Affinity DataIC50: 5.80E+3nMAssay Description:Inhibition of recombinant human 6His-tagged PAD3 expressed in Escherichia coli BL21-DE3 pLysS assessed as reduction in residual activity preincubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355657(CHEMBL1962361 | CHEMBL1910972)
Affinity DataIC50: 6.00E+3nMAssay Description:Irreversible inhibition of PAD3 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535207(CHEMBL4449566)
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of recombinant human 6His-tagged PAD3 expressed in Escherichia coli BL21-DE3 pLysS assessed as reduction in residual activity preincubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535208(CHEMBL4547728)
Affinity DataIC50: 1.07E+4nMAssay Description:Inhibition of recombinant human 6His-tagged PAD3 expressed in Escherichia coli BL21-DE3 pLysS assessed as reduction in residual activity preincubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535205(CHEMBL4461562)
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of recombinant human 6His-tagged PAD3 expressed in Escherichia coli BL21-DE3 pLysS assessed as reduction in residual activity preincubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535201(CHEMBL4442207)
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of recombinant human 6His-tagged PAD3 expressed in Escherichia coli BL21-DE3 pLysS assessed as reduction in residual activity preincubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50581394(CHEMBL5093554)
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of PAD3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355656(CHEMBL1910970)
Affinity DataIC50: 3.40E+4nMAssay Description:Irreversible inhibition of PAD3 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50535202(CHEMBL4546087)
Affinity DataIC50: 6.50E+4nMAssay Description:Inhibition of recombinant human 6His-tagged PAD3 expressed in Escherichia coli BL21-DE3 pLysS assessed as reduction in residual activity preincubated...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355658(CHEMBL1910973)
Affinity DataIC50: 3.67E+5nMAssay Description:Irreversible inhibition of PAD3 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355657(CHEMBL1962361 | CHEMBL1910972)
Affinity DataKi:  2.80E+4nMAssay Description:Irreversible inhibition of PAD3 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355665(CHEMBL1910971)
Affinity DataKi:  2.90E+4nMAssay Description:Irreversible inhibition of PAD3 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetProtein-arginine deiminase type-3(Human)
The Scripps Research Institute-Florida

Curated by ChEMBL
LigandPNGBDBM50355658(CHEMBL1910973)
Affinity DataKi:  2.93E+5nMAssay Description:Irreversible inhibition of PAD3 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluoromet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed